Molecular pathogenesis of multiple myeloma

Area of Science:

• Hematology
• Oncology
• Genomics

Background:

• Multiple myeloma (MM) is a complex bone marrow malignancy with poor prognosis despite novel therapies.
• MM progresses from monoclonal gammopathy of undetermined significance (MGUS) through clonal plasma cell expansion.
• Current treatments struggle to overcome MM due to its intricate nature.

Purpose of the Study:

• To elucidate the complex genomic landscape of multiple myeloma.
• To understand the subclonal evolution patterns in MM progression.
• To identify therapeutic strategies targeting the genomic diversity of MM.

Main Methods:

• Next-generation sequencing (NGS) was employed to analyze the genomic architecture of MM.
• The study investigated clonal and subclonal evolution from MGUS to advanced MM.
• Genomic data was correlated with disease progression and phenotypes.

Main Results:

• MM exhibits complex genomic architecture with significant subclonal evolution, challenging linear progression models.
• Minor clones present at the MGUS stage can expand, leading to relapse or leukemic conversion.
• Distinct subclones possess unique mutations and drug sensitivities.

Conclusions:

• MM progression is characterized by branching subclonal evolution rather than a simple linear accumulation of mutations.
• Eradicating all MM clones, including minor subclones, is essential for improving patient outcomes.
• Future MM treatment strategies must incorporate the genomic landscape to achieve complete eradication.